{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:18:59Z","timestamp":1771564739529,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872123"],"award-info":[{"award-number":["81872123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Provincial Higher Education Innovation Team"},{"DOI":"10.13039\/501100012467","name":"Distinguished Professor of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012467","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Medical University\u2019s 2018 Discipline Construction \u201cMajor Special Construction Plan\u201d","award":["3110118029"],"award-info":[{"award-number":["3110118029"]}]},{"name":"Outstanding Scientific Fund of Shengjing Hospital","award":["201601"],"award-info":[{"award-number":["201601"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Emerging evidence shows that abnormal expression of long non-coding RNA is involved in the occurrence and development of various tumors. LncRNA MONC is abnormally expressed in head and neck squamous cell carcinoma, lung cancer, colorectal cancer, and acute megakaryocytic leukemia, but the biological function and potential regulatory mechanism of MONC in endometrial cancer stem cells (ECSCs) and endometrial cancer cells (ECCs) have not been studied. In this study, we aimed to explore the tumor suppressive effect and mechanism of MONC in regulating ECSCs and ECCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used qRT-PCR to detect the expression of MONC, miR-636 and GLCE in normal human endometrial tissues and endometrial carcinoma (EC) tissues. Luciferase assay was used to verify the binding sites between MONC and miR-636 and between miR-636 and GLCE. Double fluorescence in situ hybridization was used to locate MONC and miR-636 in cells. ECSCs were obtained by flow cytometry sorting assay. Sphere formation assay, CCK-8 assay, transwell invasion assay, cell cycle analysis and apoptosis assay were used to detect the effects of MONC\/miR-636\/GLCE axis on the malignant biological behavior of ECSCs and ECCs. The effect of MONC on the epithelial-to-mesenchymal transition (EMT) process was detected using western blot. Finally, we conducted in vivo verification through Tumor xenografts in BALB\/C nude mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we found MONC is low expression in endometrial carcinoma (EC) and patients in the MONC high-expression group had a better prognosis. MONC and miR-636 are relatively co-localized in the cytoplasm. MONC directly inhibits the malignant biological behavior of ECSCs and ECCs by directly inhibiting miR-636. Simultaneously, miR-636 may indirectly reduce the expression of MONC. Down-regulation of miR-636 may promote GLCE expression by targeting the 3\u2032-untranslated region (UTR) of the downstream gene GLCE, thereby inhibiting the progression of ECSCs. MONC combined with miR-636 inhibited tumor epithelial-to-mesenchymal transition (EMT) process. In addition, we verified the tumor suppressive effect of MONC in nude mice, miR-636 can rescue the tumor suppressive effect of overexpressing MONC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In conclusion, this study showed that MONC inhibits the malignant phenotypes of ECSCs and ECCs by regulating the miR-636\/GLCE axis. Thus the MONC\/miR-636\/GLCE axis may provide novel treatment avenues for human EC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12935-021-01911-1","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T09:03:27Z","timestamp":1625043807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636\/GLCE axis"],"prefix":"10.1186","volume":"21","author":[{"given":"Yibing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianing","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-3196","authenticated-orcid":false,"given":"Xiaoxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1911_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine neoplasms, version 12018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170\u201399.","journal-title":"J Natl Compr Canc Netw."},{"key":"1911_CR3","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL. Wahl, GM Cancer stem cells\u2013perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339\u201344.","journal-title":"Cancer Res"},{"issue":"6","key":"1911_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","volume":"10","author":"JE Visvader","year":"2012","unstructured":"Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):717\u201328.","journal-title":"Cell Stem Cell"},{"issue":"11","key":"1911_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5732\/cjc.013.10170","volume":"32","author":"T Huang","year":"2013","unstructured":"Huang T, Alvarez A, Hu B, Cheng SY. Noncoding RNAs in cancer and cancer stem cells. Chin J Cancer. 2013;32(11):582\u201393.","journal-title":"Chin J Cancer"},{"key":"1911_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biocel.2019.01.003","volume":"108","author":"Z Ma","year":"2019","unstructured":"Ma Z, Wang Y, Xin H, et al. The expanding roles of long non-coding RNAs in the regulation of cancer T stem cells. Int J Biochem Cell Biol. 2019;108:17\u201320.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1911_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bbrc.2017.06.070","volume":"490","author":"F Kong","year":"2017","unstructured":"Kong F, Li D, Yang H, et al. Preliminary identification of endometrial cancer stem cells in vitro and in vivo. Biochem Biophys Res Commun. 2017;490(2):506\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1007\/s00216-019-01607-6","volume":"411","author":"R Miranda-Castro","year":"2019","unstructured":"Miranda-Castro R, De-Los-Santos-\u00c1lvarez N, Lobo-Casta\u00f1\u00f3n MJ. Long noncoding RNAs: from genomic junk to rising stars in the early detection of cancer. Anal Bioanal Chem. 2019;411(19):4265\u201375.","journal-title":"Anal Bioanal Chem."},{"key":"1911_CR9","doi-asserted-by":"publisher","first-page":"109396","DOI":"10.1016\/j.biopha.2019.109396","volume":"119","author":"H Liu","year":"2019","unstructured":"Liu H, Wan J, Chu J. Long non-coding RNAs and endometrial cancer. Biomed Pharmacother. 2019;119:109396.","journal-title":"Biomed Pharmacother"},{"key":"1911_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fonc.2019.00898","volume":"9","author":"B Yang","year":"2019","unstructured":"Yang B, Shen J, Xu L, et al. Genome-wide identification of a novel eight-lncRNA signature to improve prognostic prediction in head and neck squamous cell carcinoma. Front Oncol. 2019;9:898\u2013913.","journal-title":"Front Oncol"},{"key":"1911_CR11","doi-asserted-by":"publisher","first-page":"e4254","DOI":"10.7717\/peerj.4254","volume":"6","author":"P Ning","year":"2018","unstructured":"Ning P, Wu Z, Hu A, et al. Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets. PeerJ. 2018;6:e4254.","journal-title":"PeerJ"},{"issue":"4","key":"1911_CR12","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1016\/j.bbrc.2018.08.075","volume":"503","author":"F Huang","year":"2018","unstructured":"Huang F, Wen C, Zhuansun Y, et al. A novel long noncoding RNA OECC promotes colorectal cancer development and is negatively regulated by miR-143-3p. Biochem Biophys Res Commun. 2018;503(4):2949\u201355.","journal-title":"Biochem Biophys Res Commun"},{"key":"1911_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1476-4598-13-171","volume":"13","author":"S Emmrich","year":"2014","unstructured":"Emmrich S, Streltsov A, Schmidt F, et al. LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia. Mol Cancer. 2014;13:171.","journal-title":"Mol Cancer"},{"issue":"2","key":"1911_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"3","key":"1911_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143\u201359.","journal-title":"EMBO Mol Med"},{"issue":"23","key":"1911_CR16","doi-asserted-by":"publisher","first-page":"11314","DOI":"10.18632\/aging.102530","volume":"11","author":"Q He","year":"2019","unstructured":"He Q, Huang L, Yan D, et al. CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9. Aging (Albany NY). 2019;11(23):11314\u201328.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1038\/emm.2013.1","volume":"45","author":"JY Jang","year":"2013","unstructured":"Jang JY, Lee YS, Jeon YK, et al. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma. Exp Mol Med. 2013;45(1):e3.","journal-title":"Exp Mol Med"},{"issue":"6","key":"1911_CR18","first-page":"468","volume":"93","author":"MM Braun","year":"2016","unstructured":"Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2016;93(6):468\u201374.","journal-title":"Am Fam Physician"},{"key":"1911_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","volume":"11","author":"D Nassar","year":"2016","unstructured":"Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev Pathol. 2016;11:47\u201376.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1911_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/0471141755.ph1425s61","volume":"61","author":"B Bao","year":"2013","unstructured":"Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH. Cancer stem cells (CSCS) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol. 2013;61(1):14\u201325.","journal-title":"Curr Protoc Pharmacol."},{"issue":"5","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","volume":"51","author":"M Katoh","year":"2017","unstructured":"Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017;51(5):1357\u201369.","journal-title":"Int J Oncol"},{"issue":"20","key":"1911_CR22","first-page":"30253","volume":"S1535\u20136108","author":"GL Coles","year":"2020","unstructured":"Coles GL, Cristea S, Webber JT, et al. Unbiased proteomic profiling uncovers a targetable GNAS\/PKA\/PP2A axis in small cell lung cancer stem cells. Cancer Cell. 2020;S1535\u20136108(20):30253\u201361.","journal-title":"Cancer Cell"},{"issue":"6","key":"1911_CR23","doi-asserted-by":"publisher","first-page":"E1392","DOI":"10.3390\/cells9061392","volume":"9","author":"PK Das","year":"2020","unstructured":"Das PK, Islam F, Lam AK. The roles of cancer stem cells and therapy resistance in colorectal carcinoma. Cells. 2020;9(6):E1392.","journal-title":"Cells"},{"issue":"5","key":"1911_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/cancers11050653","volume":"11","author":"SJ Kitson","year":"2019","unstructured":"Kitson SJ, Rosser M, Fischer DP, et al. Targeting endometrial cancer stem cell activity with metformin is inhibited by patient-derived adipocyte-secreted factors. Cancers (Basel). 2019;11(5):653.","journal-title":"Cancers (Basel)"},{"key":"1911_CR25","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.2147\/IJN.S200480","volume":"14","author":"Y Gao","year":"2019","unstructured":"Gao Y, Qian H, Tang X, et al. Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth. Int J Nanomedicine. 2019;14:2719\u201331.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13045-017-0428-9","volume":"10","author":"X Huang","year":"2017","unstructured":"Huang X, Xiao R, Pan S, et al. Uncovering the roles of long non- coding RNAs in cancer stem cells. J Hematol Oncol. 2017;10(1):62.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1911_CR27","doi-asserted-by":"publisher","first-page":"e0170860","DOI":"10.1371\/journal.pone.0170860","volume":"12","author":"J Deng","year":"2017","unstructured":"Deng J, Yang M, Jiang R, et al. Long non-coding RNA HOTAIR regulates the proliferation, self-renewal capacity, tumor formation and migration of the cancer stem-like cell (CSC) subpopulation enriched from breast cancer cells. PLoS ONE. 2017;12(1):e0170860.","journal-title":"PLoS ONE"},{"issue":"12","key":"1911_CR28","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/stem.1547","volume":"31","author":"C P\u00e1dua Alves","year":"2013","unstructured":"P\u00e1dua Alves C, Fonseca AS, Muys BR. Brief report: The lincRNA Hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells. 2013;31(12):2827\u201332.","journal-title":"Stem Cells"},{"issue":"17","key":"1911_CR29","doi-asserted-by":"publisher","first-page":"e101110","DOI":"10.15252\/embj.2018101110","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhu P, Luo J, et al. LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling. EMBO J. 2019;38(17):e101110.","journal-title":"EMBO J"},{"issue":"1","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-019-1239-3","volume":"38","author":"DM Wu","year":"2019","unstructured":"Wu DM, Zheng ZH, Zhang YB, et al. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells. J Exp Clin Cancer Res. 2019;38(1):237.","journal-title":"J Exp Clin Cancer Res"},{"key":"1911_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12935-020-01510-6","volume":"20","author":"Q Meng","year":"2020","unstructured":"Meng Q, Wang X, Xue T, et al. Long noncoding RNA MIR99AHG promotes gastric cancer progression by inducing EMT and inhibiting apoptosis via miR577\/FOXP1 axis. Cancer Cell Int. 2020;20:414.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"1911_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinform. 2016;14(1):42\u201354.","journal-title":"Genomics Proteomics Bioinform"},{"key":"1911_CR33","doi-asserted-by":"crossref","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505(7483): 344\u2013352.","DOI":"10.1038\/nature12986"},{"issue":"11","key":"1911_CR34","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1111\/jcmm.15261","volume":"24","author":"L Han","year":"2020","unstructured":"Han L, Yan Y, Zhao L, et al. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p\/WNT1 pathway. J Cell Mol Med. 2020;24(11):6242\u201352.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1911_CR35","first-page":"5391","volume":"24","author":"JH Xu","year":"2020","unstructured":"Xu JH, Chen RZ, Liu LY, et al. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p\/HMGA2 axis. Eur Rev Med Pharmacol Sci. 2020;24(10):5391\u2013403.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"18","key":"1911_CR36","first-page":"30169","volume":"S0167\u20134889","author":"F Kong","year":"2018","unstructured":"Kong F, Ma J, Yang H, et al. Long non-coding RNA PVT1 promotes malignancy in human endometrial carcinoma cells through negative regulation of miR-195-5p. Biochim Biophys Acta Mol Cell Res. 2018;S0167\u20134889(18):30169\u201371.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"3","key":"1911_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41419-018-0291-9","volume":"9","author":"X Pan","year":"2018","unstructured":"Pan X, Li D, Huo J, et al. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p\/miR-3130-3p\/NFYA\/SATB1 axis. Cell Death Dis. 2018;9(3):303.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1911_CR38","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ygyno.2014.02.033","volume":"133","author":"X Zhou","year":"2014","unstructured":"Zhou X, Gao Q, Wang J, et al. Linc-RNA-RoR acts as a \u201csponge\u201d against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol. 2014;133(2):333\u20139.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1911_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RYJ. RYJ Huang, MANieto, Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390.","journal-title":"Cell"},{"issue":"1\u20132","key":"1911_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","volume":"28","author":"O Schmalhofer","year":"2009","unstructured":"Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28(1\u20132):151\u201366.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"1911_CR41","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6):100773.","journal-title":"Transl Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-01911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-021-01911-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-01911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T09:06:19Z","timestamp":1625043979000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-021-01911-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1186\/s12935-021-01911-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Committee (Ethical No. 2018PS251K, 2018PS136K) of the Shengjing Hospital affiliated to China Medical University, and experimentation was conducted based on the approved guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests..","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}